Cost‐Effectiveness of the Early Arthritis Clinic Organizational Model
Open Access
- 5 December 2022
- journal article
- research article
- Published by Wiley in Arthritis Care & Research
- Vol. 75 (5), 1046-1051
- https://doi.org/10.1002/acr.24897
Abstract
ObjectiveEarly diagnosis and tight control improve outcomes of rheumatoid arthritis (RA). However, whether establishing an early arthritis clinic (EAC) is sustainable for national health systems is not known. This analysis aimed to compare effectiveness and costs of an EAC compared to patients followed by the current standard of care. MethodsA retrospective study on administrative health databases of patients with a new diagnosis of RA was conducted: 430 patients followed in an EAC were enrolled, and 4 non-EAC controls were randomly matched for each. During 2 years of follow-up, the mean health care costs (outpatient, inpatient, pharmaceutical, and global) and 3 effectiveness measures (number and length of hospitalization and quality of care) of the EAC and non-EAC were estimated. The incremental cost-effectiveness ratio was calculated as well as the cost-effectiveness acceptability curve. ResultsThe cohorts included patients with a mean age of 55.4 years, and 1,506 patients (70%) were female. The mean pharmaceutical (2,602 versus 1,945 euros) and outpatient (2,447 versus 1,778 euros) costs were higher in the EAC cohort. Conversely, a higher rate of non-EAC patients had a low adherence to quality-of-care indicators. The expected number of hospitalizations and the length of stay were statistically significantly higher in the non-EAC versus EAC. ConclusionDespite an expected increase in outpatient costs (visits and diagnostic tests) and pharmaceutical costs, the reduction in terms of number and length of hospitalizations and the higher adherence to international quality-of-care guidelines support the effectiveness of the EAC model.This publication has 12 references indexed in Scilit:
- Disease activity flares and pain flares in an early rheumatoid arthritis inception cohort; characteristics, antecedents and sequelaeBMC Rheumatology, 2019
- The Italian Society for Rheumatology clinical practice guidelines for rheumatoid arthritisReumatismo, 2019
- Early arthritis clinic is cost-effective, improves outcomes and reduces biologic useClinical Rheumatology, 2019
- Medical Care Costs Associated With Rheumatoid Arthritis in the US: A Systematic Literature Review and Meta‐AnalysisArthritis Care & Research, 2018
- Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registryBMC Musculoskeletal Disorders, 2013
- Early remission is associated with improved survival in patients with inflammatory polyarthritis: results from the Norfolk Arthritis RegisterAnnals Of The Rheumatic Diseases, 2013
- Median-Based Incremental Cost-Effectiveness Ratio (ICER)Journal of Statistical Theory and Practice, 2012
- Effectiveness of a clinical practice intervention in early rheumatoid arthritisArthritis Care & Research, 2011
- The incidence of rheumatoid arthritis in Spain: results from a nationwide primary care registryRheumatology, 2008
- Factors related to radiological damage in 61 Spaniards with early rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2002